Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02160041
Title BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Acronym CBGJ398XUS04
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST